Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z007852 | — |
No additional AE reported; t PROQUAD was administered during a T/E to 1 patient on 8/13/2025.; This spontaneous report was received from a Physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-AUG-2025, a temperature excursion occurred for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) at 23.3 degree Fahrenheit (F) for 5 hours, with no previous TE. On 13-AUG-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD), Injection, administered for prophylaxis (lot number Z007852 has been verified to be valid for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live [PROQUAD], expiration date 19-OCT-2026; dose, route of administration and anatomical site of injection were not reported) (Product storage error), which was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (expiration date and lot number were not reported). No additional adverse event was reported for the patient. No other information was provided. This is one of two reports from the same reporter.
sterile diluent